Cerebral Vascular Dysfunction During Hypercholesterolemia

Background and Purpose— Studies of peripheral arteries in hypercholesterolemic animals suggest that increased generation of superoxide contributes to endothelial dysfunction, especially in the presence of atherosclerotic lesions. We tested the hypothesis that vasomotor function is impaired in cerebral arterioles during hypercholesterolemia through a mechanism that involves oxidative stress. Methods— Apolipoprotein E–deficient (apoE−/−) mice were fed a normal or a high-fat diet for >6 months. ApoE+/− mice fed a normal diet were used as normocholesterolemic controls. Responses of cerebral arterioles were examined in open cranial windows in vivo in anesthetized mice. Results— In apoE−/− mice, intimal area was increased only in the proximal aorta on the normal diet and also markedly increased in the distal aorta on the high-fat diet. There were no increases in intimal area in the aortas of control mice or in the cerebral arterioles in any group. The dilator response of cerebral arterioles to ACh (10 &mgr;mol/L) in control mice (26±4% increase in diameter) was reduced in apoE−/− mice on either the normal (13±2%) or the high-fat (13±3%) diet (P<0.05 vs control). NADPH (10 &mgr;mol/L), a substrate for NADPH oxidase, produced dilator responses in control mice (8±4%) that were significantly increased in apoE−/− mice on the high-fat diet (16±2%, P<0.05 vs control). Tempol, a superoxide scavenger, and apocynin, an inhibitor of NADPH oxidase, significantly increased vasodilator responses to ACh and decreased vasodilation to NADPH in apoE−/− mice on the high-fat diet. Nitroprusside produced a similar dilatation in the cerebral arterioles of all groups. Conclusions— Hypercholesterolemia is associated with oxidative stress and endothelial dysfunction in cerebral arterioles, despite the absence of atherosclerotic lesions.

[1]  F. Faraci,et al.  Impaired Endothelium-Dependent Responses and Enhanced Influence of Rho-Kinase in Cerebral Arterioles in Type II Diabetes , 2005, Stroke.

[2]  C. Iadecola,et al.  Angiotensin II Impairs Neurovascular Coupling in Neocortex Through NADPH Oxidase–Derived Radicals , 2004, Circulation research.

[3]  G. Wang,et al.  Exogenous NADPH Increases Cerebral Blood Flow Through NADPH Oxidase–Dependent and –Independent Mechanisms , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[4]  H. Drexler,et al.  Endothelial function: a critical determinant in atherosclerosis? , 2004, Circulation.

[5]  G. Diamond,et al.  Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 1: diagnosis of stable ischemia and ischemic heart disease. , 2004, Circulation.

[6]  C. Sobey,et al.  Increased NADPH-Oxidase Activity and Nox4 Expression During Chronic Hypertension Is Associated With Enhanced Cerebral Vasodilatation to NADPH In Vivo , 2004, Stroke.

[7]  C. Sobey,et al.  Cerebral vascular effects of reactive oxygen species: Recent evidence for a role of NADPH‐oxidase , 2003, Clinical and experimental pharmacology & physiology.

[8]  R. Clempus,et al.  Vascular NAD(P)H oxidases: specific features, expression, and regulation. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  J. Shepherd,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial , 2003 .

[10]  Barry R. Davis,et al.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). , 2002, JAMA.

[11]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[12]  R. Latorre,et al.  Ca2+-Activated K+ Channel Inhibition by Reactive Oxygen Species , 2002 .

[13]  F. Faraci,et al.  Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. , 2002, American journal of physiology. Heart and circulatory physiology.

[14]  Leslie A. Smith,et al.  Hypercholesterolemia Impairs Endothelium-Dependent Relaxations in Common Carotid Arteries of Apolipoprotein E-Deficient Mice , 2001, Stroke.

[15]  Leslie A. Smith,et al.  Mechanism of Endothelial Dysfunction in Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[16]  D. Granger,et al.  NAD(P)H Oxidase—Derived Superoxide Mediates Hypercholesterolemia-Induced Leukocyte—Endothelial Cell Adhesion , 2001, Circulation research.

[17]  D. Heistad,et al.  Mechanisms That Produce Nitric Oxide–Mediated Relaxation of Cerebral Arteries During Atherosclerosis , 2001, Stroke.

[18]  N. Brot,et al.  Oxidative Regulation of Large Conductance Calcium-Activated Potassium Channels , 2001, The Journal of general physiology.

[19]  R. Cohen,et al.  Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E-deficient mice. , 2000, Journal of cardiovascular pharmacology.

[20]  B. Fanburg,et al.  Reactive oxygen species in cell signaling. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[21]  N. Holbrook,et al.  Oxidants, oxidative stress and the biology of ageing , 2000, Nature.

[22]  D. Sorescu,et al.  Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Tsung-Yu Chen,et al.  Cysteine Modification of a Putative Pore Residue in Clc-0 , 2000, The Journal of general physiology.

[24]  D. Heistad,et al.  Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[25]  C. Mallari,et al.  Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[26]  W. Lederer,et al.  Calcium sparks in smooth muscle. , 2000, American journal of physiology. Cell physiology.

[27]  Francisco Bezanilla,et al.  Modulation of the Shaker K+Channel Gating Kinetics by the S3–S4 Linker , 2000, The Journal of general physiology.

[28]  A. Demchuk,et al.  Is cholesterol a risk factor for stroke?: Yes. , 1999, Archives of neurology.

[29]  W. Landau,et al.  Is cholesterol a risk factor for stroke?: No. , 1999, Archives of neurology.

[30]  V. Hachinski Cholesterol as a Risk Factor for Stroke , 1999 .

[31]  D. Harrison,et al.  Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. , 1999, Circulation.

[32]  B. Davis,et al.  Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. , 1999, Circulation.

[33]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[34]  M. Pfeffer,et al.  Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. , 1998, Circulation.

[35]  J. Kourie,et al.  Interaction of reactive oxygen species with ion transport mechanisms. , 1998, American journal of physiology. Cell physiology.

[36]  T. Lüscher,et al.  Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. , 1998, Circulation.

[37]  D. Harrison,et al.  Vascular expression of extracellular superoxide dismutase in atherosclerosis. , 1998, The Journal of clinical investigation.

[38]  D. Heistad,et al.  Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[39]  J. Arnal,et al.  17β-Estradiol Prevents Fatty Streak Formation in Apolipoprotein E–Deficient Mice , 1997 .

[40]  L. Annunziato,et al.  Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  N. Brot,et al.  Modulation of potassium channel function by methionine oxidation and reduction. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Salkoff,et al.  A novel calcium-sensing domain in the BK channel. , 1997, Biophysical journal.

[43]  R. Sauvé,et al.  Effects of Thiol-Modifying Agents on a K(Ca2+) Channel of Intermediate Conductance in Bovine Aortic Endothelial Cells , 1997, The Journal of Membrane Biology.

[44]  Yong-Xiao Wang,et al.  Redox Regulation of Large Conductance Ca2+-activated K+ Channels in Smooth Muscle Cells , 1997, The Journal of general physiology.

[45]  P. Reinhart,et al.  Redox Modulation of hslo Ca2+-Activated K+ Channels , 1997, The Journal of Neuroscience.

[46]  R. Latorre,et al.  Voltage-controlled gating in a large conductance Ca2+-sensitive K+channel (hslo). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Sobey,et al.  Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. , 1997, Stroke.

[48]  M. Yamaguchi,et al.  H2O2 modulates twitch tension and increases Po of Ca2+ release channel in frog skeletal muscle. , 1996, The American journal of physiology.

[49]  M. Kakei,et al.  Direct activation of the ATP-sensitive potassium channel by oxygen free radicals in guinea-pig ventricular cells: its potentiation by MgADP. , 1996, Journal of molecular and cellular cardiology.

[50]  J. Neyton A Ba2+ chelator suppresses long shut events in fully activated high-conductance Ca(2+)-dependent K+ channels. , 1996, Biophysical journal.

[51]  R. Busse,et al.  Endothelial dysfunction in atherosclerosis. , 1996, Journal of vascular research.

[52]  R. Latorre,et al.  Interaction of internal Ba2+ with a cloned Ca(2+)-dependent K+ (hslo) channel from smooth muscle , 1996, The Journal of general physiology.

[53]  M. Lazdunski,et al.  Susceptibility of cloned K+ channels to reactive oxygen species. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Rubart,et al.  Relaxation of Arterial Smooth Muscle by Calcium Sparks , 1995, Science.

[55]  K. Pritchard,et al.  Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. , 1995, Circulation research.

[56]  A. Quyyumi,et al.  Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. , 1995, The Journal of clinical investigation.

[57]  C. Sen,et al.  Inward potassium transport systems in skeletal muscle derived cells are highly sensitive to oxidant exposure. , 1995, Free radical biology & medicine.

[58]  M. Kasha,et al.  Singlet molecular oxygen in the Haber-Weiss reaction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Turrens,et al.  Hydrogen peroxide metabolism in skeletal muscle mitochondria. , 1994, Archives of biochemistry and biophysics.

[60]  Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[61]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[62]  A. J. Williams,et al.  Modification of the gating of the cardiac sarcoplasmic reticulum Ca(2+)-release channel by H2O2 and dithiothreitol. , 1994, The American journal of physiology.

[63]  O. H. Bing Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. , 1994, Journal of molecular and cellular cardiology.

[64]  E. Stefani,et al.  Calcium-activated K+ channels as modulators of human myometrial contractile activity. , 1993, The American journal of physiology.

[65]  D. Harrison,et al.  Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.

[66]  B. Rudy,et al.  Modulation of K+ channels by hydrogen peroxide. , 1992, Biochemical and biophysical research communications.

[67]  P. Black,et al.  L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. , 1991, The Journal of clinical investigation.

[68]  O. Aruoma,et al.  Copper-ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. , 1991, The Biochemical journal.

[69]  B. Neumcke,et al.  ATP-sensitive potassium channels in adult mouse skeletal muscle: Characterization of the ATP-binding site , 1989, The Journal of Membrane Biology.

[70]  R. Latorre,et al.  Mechanisms of Cs+ blockade in a Ca2+-activated K+ channel from smooth muscle. , 1987, Biophysical journal.

[71]  G. Brooks,et al.  Free radicals and tissue damage produced by exercise. , 1982, Biochemical and biophysical research communications.

[72]  R. Latorre,et al.  Reconstitution in planar lipid bilayers of a Ca2+-dependent K+ channel from transverse tubule membranes isolated from rabbit skeletal muscle. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[73]  F J Sigworth,et al.  Covariance of nonstationary sodium current fluctuations at the node of Ranvier. , 1981, Biophysical journal.

[74]  F. Sigworth The variance of sodium current fluctuations at the node of Ranvier , 1980, The Journal of physiology.

[75]  J. Popper,et al.  Factors Related to Stroke Incidence in Hawaii Japanese Men: The Honolulu Heart Study , 1980, Stroke.

[76]  W. Kannel,et al.  VASCULAR DISEASE OF THE BRAIN--EPIDEMIOLOGIC ASPECTS: THE FARMINGHAM STUDY. , 1965, American journal of public health and the nation's health.

[77]  R. Latorre,et al.  Ca(2+)-activated K+ channel inhibition by reactive oxygen species. , 2002, American journal of physiology. Cell physiology.

[78]  HOMAS,et al.  The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels , 2000 .

[79]  R. Latorre,et al.  Voltage-Gated Calcium-Modulated Potassium Channels of Large Unitary Conductance: Structure, Diversity, and Pharmacology , 2000 .

[80]  J. Kastelein,et al.  Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. , 1997, The Journal of clinical investigation.

[81]  B. P. Yu,et al.  Cellular defenses against damage from reactive oxygen species. , 1994, Physiological reviews.

[82]  P. Poole‐Wilson,et al.  Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. , 1991, Cardioscience.

[83]  R Latorre,et al.  Varieties of calcium-activated potassium channels. , 1989, Annual review of physiology.